✓
Open
23 Sep 2025
✓
Close
25 Sep 2025
3
Allotment
—
✓
Listing
Tue, Sep 30, 2025
Price Band
₹65 to ₹70
Issue Size
18,60,000 shares (agg. up to ₹13 Cr)
Lot Size
2,000 Shares
Listing Date
Tue, Sep 30, 2025
Latest GMP
₹4
Est. Gain
5.71%
✦ AI Insight
GMP Trend
30-09-2025₹4Est. ₹74+5.71%
29-09-2025₹4Est. ₹74+5.71%
28-09-2025₹4Est. ₹74+5.71%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 16.28x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 21.92 | 10.03 | 6.22 |
| Total Income | 24.64 | 17.88 | 13.90 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| EBITDA | 4.76 | 1.49 | 0.57 |
| NET Worth | 6.97 | 1.77 | 0.97 |
| Reserves and Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowing | 10.36 | 5.31 | 2.21 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹110.00 |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹117.00 |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.55 |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹201.86 |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.61 |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,509.80 |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,647.10 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Office Premises with furniture and Industrial Racks | 1.63 |
| 2 | Working Capital | 8.00 |
| 3 | General Corporate Purposes | 1.91 |
| 4 | Issue Expenses | 1.48 |
| Total | 13.02 |
About Aptus Pharma IPO
Updated on Aug 5, 2026
Contact Details
Aptus Pharma Ltd. AddressAshutosh Buildcon, Opp.Slok-2Nr.Harikrupa Logistic ParkAslali, DaskroiAhmedabad, Gujarat, 382427+91 76004 27827info@aptuspharma.comVisit Website